Decent Medipharm

Abevmy 400 mg is a biosimilar intravenous injection containing bevacizumab, an anti-cancer medication used to treat several types of cancer by inhibiting the growth of new blood vessels that feed tumors. This treatment must be administered by a qualified healthcare professional. 

100mg Bevacirel Bevacizumab Injection is an anti-cancer medication that, by inhibiting new blood vessel growth, helps slow tumor growth in cancers like those of the colon, rectum, lung, kidney, and ovary. It is administered intravenously as an infusion and is often used in combination with other chemotherapy drugs. Treatment is closely monitored by a healthcare professional, as it can cause side effects and impair wound healing. 

Bryxta 400mg injection is a brand name for the anticancer drug bevacizumab, a type of targeted therapy. It is used to treat several types of advanced cancers, typically in combination with other chemotherapy agents. 

Bevacirel (bevacizumab) 400mg injection is an anti-cancer medication used to treat several types of advanced cancers, often in combination with chemotherapy. The treatment works by inhibiting the growth of new blood vessels that feed tumors, which slows cancer progression and spread. 

Krabeva 100mg (bevacizumab) is a targeted anticancer therapy that works by inhibiting the growth of blood vessels that supply tumors with oxygen and nutrients. It is administered via intravenous (IV) infusion by a healthcare professional, often in combination with other chemotherapy drugs. 

Krabeva 400mg injection is an anti-cancer medication containing bevacizumab, a biosimilar of the drug Avastin. It is used with chemotherapy to treat various cancers by blocking the blood supply to tumors. 

Bevatas is a brand name for the anticancer drug bevacizumab, a type of targeted therapy used to treat various cancers. The 300mg concentrate for injection is administered intravenously (through a vein) by a healthcare professional in a hospital or clinic setting. 

Cizumab 100mg injection is an anticancer medication containing bevacizumab, a monoclonal antibody used to treat various advanced and metastatic cancers. The treatment works by inhibiting the growth of new blood vessels that feed tumors, which slows the progression of the cancer.